To capture a wide variety of CTCs including tumor cells without EpCAM expression, we have developed a novel microfluidic system (“universal CTC-chip system”) in which any antibody to capture CTCs is easily conjugated [12,13,14,15,16]. This evidence concerns the gene EPCAM and neoplasm.